Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 281
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02219633 | Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD) | ||
| NCT01447758 | Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis. | ||
| NCT03898583 | Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis. | ||
| NCT03442244 | Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects | ||
| NCT02935582 | PSOREAL - Managing PSOriasis in the REAL World | ||
| NCT00404196 | LEO19123 Cream in the Treatment of Hand Eczema | ||
| NCT02424305 | Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions | ||
| NCT05332366 | A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia | ||
| NCT00986856 | Fucidin® Cream in the Treatment of Impetigo | ||
| NCT02387853 | Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis | ||
| NCT02549339 | Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up | ||
| NCT02881346 | Efficacy and Tolerability of Enstilar® in Daily Practice | ||
| NCT04301362 | Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients | ||
| NCT00758862 | The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo | ||
| NCT00779792 | Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation | ||
| NCT01461655 | Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris | ||
| NCT01120223 | Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis | ||
| NCT01803022 | Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer | ||
| NCT01722812 | Cromoglicate in Psoriasis | ||
| NCT07013201 | A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis | ||
| NCT00626795 | Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL) | ||
| NCT03710044 | Investigation of Flare and Remission in Subjects With Atopic Dermatitis | ||
| NCT02103725 | A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis | ||
| NCT03812198 | A Trial to Investigate the Safety, Tolerability, and Drug Levels in Blood After Single and Multiple Doses of LEO 32731 in Healthy People | ||
| NCT02361216 | Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest | ||
| NCT01302925 | PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects | ||
| NCT06884163 | Immune Signature of Chronic Hand Eczema Unveiled by Spatial Transcriptomics and Single-Cell Proteomics | ||
| NCT03562377 | Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5) | ||
| NCT02547363 | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up | ||
| NCT01930396 | Use of Tinzaparin for Anticoagulation in Hemodialysis | ||
| NCT00216827 | Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis | ||
| NCT01025635 | Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea | ||
| NCT01587755 | Optimising Outpatient Care in Mild to Moderate Psoriasis (PSO-TOP) | ||
| NCT05625932 | TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer | ||
| NCT05923099 | A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis | ||
| NCT02242747 | Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic Keratosis | ||
| NCT03114618 | A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient | ||
| NCT05194540 | Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA) | ||
| NCT02695940 | Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis | ||
| NCT07487948 | Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris | ||
| NCT01926496 | Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% | ||
| NCT04306315 | Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight | ||
| NCT02354391 | Ingenol Mebutate (Picato®) With Methyl Aminolevulinate Photodynamic Therapy for the Treatment of Actinic Keratosis | ||
| NCT00691002 | Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin Folds | ||
| NCT01043224 | A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris | ||
| NCT01007383 | LEO 27847 - A Study in Healthy Male Subjects | ||
| NCT00670241 | Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle Alone in Patients With Psoriasis Vulgaris | ||
| NCT02305888 | Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively | ||
| NCT01768013 | The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris | ||
| NCT03478280 | Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis |
